Aptamer antagonists of myelin-derived inhibitors promote axon growth

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Wang, Yuxuan ^a   Khaing, Zin Z ^b   Li, Na ^a   Hall, Brad ^a   Schmidt, Christine E ^b   Ellington, Andrew D ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b The University of Texas at Austin   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN; PROTEIN NOGO;

ANIMAL; ARTICLE; BINDING COMPETITION; CENTRAL NERVOUS SYSTEM; CHEMISTRY; CYTOLOGY; KINETICS; METABOLISM; MYELIN SHEATH; NERVE CELL; NERVE FIBER; NEURITE; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL GANGLION;

ANIMALS; AXONS; BINDING, COMPETITIVE; CENTRAL NERVOUS SYSTEM; GANGLIA, SPINAL; KINETICS; MYELIN PROTEINS; MYELIN SHEATH; NEURITES; NEURONS; RATS; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 77954965749     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009726     Document Type: Article

References (41)

1. Fournier AE, GrandPre T, Strittmatter SM (2001) Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409: 341-346.
2. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, et al. (2002) Myelin-associated glycoprotein interacts with the Nogo-66 receptor to inhibit neurite outgrowth. Neuron 35: 283-290.
3. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z (2002) P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG, and OMgp. Nature 420: 74-78.
4. Takei Y (2009) Phosphorylation of Nogo Receptors Suppresses Nogo Signaling, Allowing Neurite Regeneration. Sci Signal 2: ra14.
5. Yamashita T, Tohyama M (2003) The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nature Neurosci 6: 461-467.
6. Schnell L, Schwab ME (1990) Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature 343: 269-272.
7. Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, Gao D, et al. (1995) Recovery from spional cord injury mediated by antibodies to neuurite growth inhibitors. Nature 378: 498-501.
8. Dergham P, Ellezam B, Essagian C, Avedissian H, Lubell WD, et al. (2002) Rho signaling pathway targeted to promote spinal cord repair. J Neurosci 22: 6570-6577.
9. Fournier AE, Takizawa BT, Strittmatter SM (2003) Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 23: 1416-1423.
10. GrandPre T, Li S, Strittmatter SM (2002) Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417: 547-551.
11. Li S, Liu BP, Budel S, Li M, Ji B, et al. (2004) Blockade of Nogo-66, Myelinassociated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci 24: 10511-10521.
12. Jayasena SD (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 45: 1628-1650.
13. Rimmele M (2003) Nucleic acid aptamers as toold and drugs: recent developments. Chembiochem 4: 963-971.
14. Nimjee SM, Rusconi CP, Sullenger BA (2005) Aptamers: an emerging class of therapeutics. Annu Rev Med 56: 555-583.
15. Lee J, Stovall G, Ellington A (2006) Aptamer therapeutics advance. Curr Opin Chem Biol 10: 282-289.
16. Eyetech Study Group (2002) Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age relative macular degeneration. Retina 22: 143-152.
17. Eyetech Study Group (2003) Antivascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age related macular degeneration: Phase II study results. Ophthalmology 110: 979-986.
18. Cunningham ET, Jr., Adamis AP, Altaweel M, Aiello LP, Bressler NM, et al. (2005) A phase II randomized double-masked trial of pegaptanib, an antivascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112: 1747-1757.
19. Ng EW, Adamis AP (2005) Targeting Angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 40: 352-358.
20. Siddqui MA, Keating GM (2005) Pegaptanib in exudative age-related macular degeneration. Drugs 65: 1571-1577, discussion 1578-1579.
21. Rentmeister A, Bill A, Wahle T, Walter J, Famulok MM (2006) RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of betasecretase ACE1 in vitro. RNA 12: 1650-1660.
22. Ylera F, Lurz R, Erdmann VA, Furste JP (2002) Selection of RNA aptamers to the Alzheimer's disease amyloid peptide. Biochem Biophys Res Commun 290: 1583-1588.
23. Burmeister PE, Wang C, Killough JR, Lewis SD, Horwitz LR, et al. (2006) 29-Deoxy purine, 29-O-methyl pyrimidine (dRmY) aptamers as candidate therapeutics. Oligonucleotides: 16: 337-351.
24. Pendergrast PS, Thompson KM, Ferguson A, Kilough J, Horwitz L, et al. (2006) Aptamers that discriminate between IL-23 and IL-12 are specific inhibitors of IL-23 and IL-12 are specific inhibitors of IL-23 activity in vitro. GTC Bio 4th Annual Conference on Cytokines and Inflammation. San Diego California. pp 109-111.
25. Lee SW, Sullenger BA (1997) Isolation of a nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies. Nat Biotechnol 15: 41-45.
26. Seo, HS, Lee SW (2000) In vitro selectin of the 29-fluror-29deoxyribonucleotide decoy RNA inhibitor of myasthenia autoantibodies. J Microbiol Biotechnol 10: 7070-7073.
27. Barton WA, Liu BP, Tzvetkova D, Jeffrey PD, Fournier AE, et al. (2003) Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J 22: 3291-3302.
28. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, et al. (2002) Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417: 941-944.
29. Ahmed Z, Mazibrada G, Seabright RJ, Dent RG, Berry M, et al. (2006) TACEinduced cleavage of NgR and p75NTR in dorsal root ganglion cultures disinhibits outgrowth and promotes branching of neurites in the presence of inhibitory CNS myelin. FASEB J 11: 1939-1941.
30. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, et al. (2000) Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403: 434-439.
31. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM (2000) Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403: 439-444.
32. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT (1994) A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13: 757-767.
33. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, et al. (1994) Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13: 805-811.
34. Fiedler M, Horn C, Bandtlow C, Schwab ME, Skerra A (2002) An engineered IN-1 F(ab) fragment with improved affinity for the Nogo-A axonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity. Protein Eng 11: 931-941.
35. Fournier AE, GrandPre T, Gould G, Wang X, Strittmatter SM (2002) Nogo and the Nogo-66 receptor. Prog Brain Res 137: 361-369.
36. Liu BP, Fournier A, GrandPré T, Strittmatter SM (2002) Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297: 1190-1193.
37. Fawcett JW, Keynes RJ (1990) Peripheral nerve regeneration. Annu Rev Neurosci 13: 43-60.
38. Josephson A, Trifunovski A, Widmer HR, Widenfalk J, Olson L, et al. (2002) Nogo-receptor gene activity: cellular localization and developmental regulation of mRNA in mice and humans. J Comp Neurol 453: 292-304.
39. David S, Aguayo AJ (1981) Axonal elongation into peripheral nervous system 'bridges' after central nervous system injury in adult rats. Science 214: 931-933.
40. Owens GC, Boyd CJ, Bunge RP, Salzer JL (1990) Expression of recombinant myelin-associated glycoprotein in primary Schwann cells promotes the initial investment of axons by myelinating Schwann cells. J Cell Biol 111: 1171-1182.
41. Dupuis L, Pehar M, Cassina P, Rene F, Castellanos R, et al. (2008) Nogo receptor antagonizes p75NTR-dependent motor neuron death. Proc Natl Acad Sci U S A 105: 740-745.